Delivery Order SPE2DB25D3012-SPE2DB25FWZYH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,728.21 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,139.62, is a delivery order for the supply of 4,562,841,156 units of Chlorothiazide Sodium 500 mg vials. The contract has an ultimate completion date of November 17, 2023, and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,399.80 firm-fixed-price delivery order is for the supply of 500 mg chlorothiazide sodium injection vials. The contract has an ultimate completion date of September 27, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a...
- This federal contract award is for the delivery of Chlorothiazide Sodium 500 mg Vials, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,484.65, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of December 22, 2023. The contract was awarded on December 21, 2023, and there is no set-aside designation indicated....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Chlorothiazide Sodium 500 mg vials, a medication used to treat high blood pressure and fluid retention. The delivery order, valued at $4,837.80, has a firm fixed price and an ultimate completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CHLOROTHIAZIDE SOD 500 MG VIALS, a pharmaceutical product, with a ceiling value of $3,635.63 and a period of performance through July 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp also...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,175.59, is for the delivery of 4566514787 CHLOROTHIAZIDE SOD 500 MG VIALS. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 22, 2024. The contract is not designated with a set-aside requirement....
- The Defense Logistics Agency awarded a $3,238 delivery order contract to Amerisourcebergen Drug Corporation for chlorothiazide sodium 500 mg vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued a requirement for this generic diuretic medication. Amerisourcebergen will deliver the vials from its Conshohocken, Pennsylvania facility on a firm fixed price basis, with performance spanning August 25-28, 2023. No subcontractors or...
- The Defense Logistics Agency awarded a $1,118.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sodium Chloride 120 mEq/30 mL pharmaceutical product on August 1, 2025, with ultimate completion by August 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- This federal contract award, valued at $20,169.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of chlorothiazide sodium 500 mg vials, a medication used for various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 9, 2024. It is not designated as a set-aside contract....
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZYHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,699.90 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical supply contracts with the DLA to support military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's established capacity to fulfill federal pharmaceutical requirements through open competition, demonstrated across its portfolio of delivery orders with firm fixed pricing structures, positions it as a key vendor for the DLA's ongoing medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/11/25 |